title: Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
authors.affiliation: 1 Division of Endocrine Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai , New York, New York.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Marti
authors.affiliation: 2 VA Outcomes Group, Veterans Affairs Medical Center , White River Junction, Vermont.
authors.forename: Louise
authors.initials: L
authors.lastname: Davies
authors.affiliation: 3 Division of Endocrinology, Department of Medicine, University of Michigan Medical School , Ann Arbor, Michigan.
authors.forename: Megan R
authors.initials: MR
authors.lastname: Haymart
authors.affiliation: 4 Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center , New York, New York.
authors.forename: Benjamin R
authors.initials: BR
authors.lastname: Roman
authors.affiliation: 5 Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York.
authors.forename: R Michael
authors.initials: RM
authors.lastname: Tuttle
authors.affiliation: 4 Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center , New York, New York.
authors.forename: Luc G T
authors.initials: LG
authors.lastname: Morris
mesh_terms: D002277:Carcinoma / Q000473:pathology / Q000532:radiotherapy*; D002291:Carcinoma, Papillary; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006297:Health Services Accessibility / Q000706:statistics & numerical data*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D018426:SEER Program; D000077273:Thyroid Cancer, Papillary; D013964:Thyroid Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D013965:Thyroidectomy; D047368:Tumor Burden; D014481:United States
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals